'%2F%3E%3Cpath%20d%3D'M6.5%2025%2016%207%2025.5%2025'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.8'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'16'%20cy%3D'19'%20r%3D'3.2'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
Invicta Diagnostic Limited
INVICTA (NSE) · ISIN INE0XJ501010 · Healthcare Service Provider · listed 2025
Not on any surveillance list
Quarterly results
No quarterly results stored for this company yet.
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹49.1 cr | ₹0 cr | ₹52.97 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 66.70% | 1.54% | 4.25% | 33.30% |
Latest filings
- Invicta Diagnostic Limited has informed the Exchange regarding Outcome of Board Meeting held on September 18, 2026 wherein Board considered and approved the proposed business outlook and forward-looki 18 September 2026 · NSE
- Annual Report FY2025-26 (New) 25 August 2026 · NSE
- Invicta Diagnostic Limited has informed the Exchange regarding Outcome of Board Meeting held on August 25, 2026. 25 August 2026 · NSE
- Invicta Diagnostic Limited has informed the Exchange regarding Outcome of Board Meeting held on July 29, 2026. Board at its meeting held today1. The Board took on record and accepted the resignation o 29 July 2026 · NSE
- Invicta Diagnostic Limited has informed the Exchange about Transcript of Earnings Conference Call with Investor and Analyst held on Saturday, 23rd May 2026. 25 May 2026 · NSE
Other companies in Healthcare Service Provider
- Dr. Lal Path Labs Ltd.
- Metropolis Healthcare Limited
- Thyrocare Technologies Limited
- Vijaya Diagnostic Centre Limited
- Krsnaa Diagnostics Limited
- One Global Service Provider Limited
- Nephrocare Health Services Limited
- Suraksha Diagnostic Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.